US drug enforcement agents have taken action against more than 200 illicit online pharmacy websites associated with a criminal network based in India. This network has been connected to fatal overdoses in the United States, with at least six deaths and four non-fatal overdoses attributed to it. The investigation into this transnational criminal organization began in 2022.
The Drug Enforcement Administration (DEA) initiated coordinated operations starting on January 27, resulting in the arrest of four individuals across the country. Additionally, authorities issued five Immediate Suspension Orders and one Order to Show Cause against DEA registrants as part of efforts to safeguard public health and safety.
Federal authorities disclosed that they have also closed down over 200 online pharmacies accused of distributing diverted pharmaceuticals and counterfeit medications without valid prescriptions. According to US law, pharmacies are only permitted to dispense controlled substances with a legitimate prescription issued by a licensed practitioner for a valid medical purpose.
The operators of the illicit websites are alleged to have flouted these regulations by unlawfully dispensing and shipping controlled drugs to customers throughout the US. This illegal scheme, in violation of the Controlled Substances Act, undermined safety measures intended to protect patients. The DEA highlighted that the investigation has identified numerous customers who made purchases from these unauthorized platforms.
DEA Administrator Terrance Cole emphasized the exploitation of the healthcare system by foreign traffickers who use online channels to distribute dangerous drugs under the guise of legitimate commerce. Cole condemned illegal online pharmacies for endangering American communities by selling unapproved and counterfeit pills without regard for the harm caused.
The DEA is collaborating with Indian law enforcement authorities to identify and dismantle criminal networks engaged in illicit pharmaceutical trafficking. Joint operations are ongoing to target illicit drug distributors at the root level. The agency noted that operators frequently collaborated with drug traffickers to fulfill online orders using counterfeit or diverted pharmaceuticals, including pills containing fentanyl or methamphetamine, which can lead to severe side effects, ineffective treatment, and even death.
